Type 2 & other diabetes

Age‐specific associations between the number of co‐morbidities, all‐cause mortality and public direct medical costs in patients with type 2 diabetes: A retrospective cohort study

Diabetes Obes MetabPublished Retrospective cohort study

Authors' conclusion

Age-specific co-morbidity patterns were observed for patients with T2D. A greater number of co-morbidities was associated with increased mortality and healthcare costs, with stronger relationships observed among younger patients.

Study context

Population
Patients with T2D in Hong Kong (electronic health records), stratified by age (<50, 50–64, 65–79, ≥80 years); co-morbidities defined by Charlson Comorbidity Index and prevalent chronic diseases from local surveys
Participants
262,212 patients
Exposure
Number of co-morbidities vs none, by age group
Outcome
All-cause mortality and public direct medical costs by number of co-morbidities across age groups
Follow-up
Median 10 years
Methodological detailselectronic health records, stratified by age and number of co-morbidities
  • Electronic health records
  • Stratified by age and number of co-morbidities

Main finding

As reported in the abstract

All-cause mortality
Each group vs 0 co-morbiditiesHazard ratio (95% CI)
2 co-morbidities, age <50
1.31(1.08–1.59)
2 co-morbidities, age ≥80
1.25(1.15–1.36)
≥4 co-morbidities, age <50
3.08(2.25–4.21)
≥4 co-morbidities, age ≥80
1.98(1.82–2.16)

Observational data: associations, not effects.

Further findings

Direct medical costs

Similar trends were observed for medical costs
  • Gamma generalized linear model with log link

Co-morbidity patterns

Hypertension and dyslipidaemia most common co-morbidities in all age groups
CVD dominated top co-morbidity pair in older ages (65-79, ≥80 years); inflammatory and liver disease predominant in younger

Original publication

Age‐specific associations between the number of co‐morbidities, all‐cause mortality and public direct medical costs in patients with type 2 diabetes: A retrospective cohort study. Diabetes Obes Metab. Published 2 November 2022. doi:10.1111/dom.14889

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.